Search any bill in Congress.

This House resolution expresses support for officially designating the third week of October as National Hunter Syndrome Awareness Week. Hunter syndrome, also known as Mucopolysaccharidosis Type II (MPS II), is a rare genetic disorder primarily affecting males, caused by a deficiency of a specific enzyme. This leads to the buildup of harmful substances in the body, causing progressive damage to organs and the brain, with symptoms typically appearing in early childhood. The condition results in developmental delays, physical challenges, and often a shortened lifespan. The resolution highlights the importance of early diagnosis and intervention to improve outcomes for affected individuals. By raising public and medical awareness, the resolution aims to encourage earlier diagnosis, better treatment options, and increased research efforts toward therapies or a cure. It also acknowledges the significant emotional, financial, and medical challenges faced by families dealing with Hunter syndrome. The resolution calls on federal agencies, research institutions, and advocacy groups to enhance education, research, and treatment development efforts, and urges Congress to continue supporting funding for rare disease research that benefits the Hunter syndrome community. While this resolution does not create new laws or funding by itself, it serves as a formal recognition and encouragement for ongoing and future efforts related to this rare disease.